 Connection
Kathryn Haskins to Cathepsin D
This is a "connection" page, showing publications Kathryn Haskins has written about Cathepsin D.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.167 |
|
|
|
-
Wenzlau JM, Mangold K, Nicholson K, Dang M, Hohenstein AC, Douglas KS, DiLisio JE, Powell R, Delong T, Haskins K, Baker RL. A novel region of the insulin B9-23 sequence is targeted by a HIP-reactive diabetogenic T cell clone. Front Immunol. 2026; 17:1837267.
Score: 0.061
-
Groegler J, Mangold K, Nicholson K, Dang M, Wenzlau J, Beard KS, Hohenstein A, Powell R, Baker R, Haskins K, Matsuda J, Delong T. Strategic Reduction of Hybrid Insulin Peptide Formation Significantly Delays Diabetes Onset in NOD Mice. Diabetes. 2026 01 01; 75(1):115-123.
Score: 0.059
-
Crawford SA, Wiles TA, Wenzlau JM, Powell RL, Barbour G, Dang M, Groegler J, Barra JM, Burnette KS, Hohenstein AC, Baker RL, Tse HM, Haskins K, Delong T. Cathepsin D Drives the Formation of Hybrid Insulin Peptides Relevant to the Pathogenesis of Type 1 Diabetes. Diabetes. 2022 12 01; 71(12):2793-2803.
Score: 0.047
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|